Law Firms Investigate Tempus AI Purchase of Cancer Diagnostic Company

Monsey, Tuesday, 4 August 2026.
Multiple law firms are scrutinizing Tempus AI’s proposed $1.5 billion acquisition of Personalis, examining whether the $16.25 per share valuation underestimates the company’s long-term growth in cancer detection.